Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Almac Group Invites Attendees to Join Workshop in San Diego to Learn About Cold Chain Management in Clinical Trials

Almac Group
Posted on: 15 Dec 18

Souderton, PA, U.S., 14 December 2018 – Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organisation the Almac Group, is pleased to invite participants from the pharmaceutical and biopharma industries to join its San Diego lunch and learn to discuss cold chain management in clinical trials.

The complimentary event will be held at the NINE-TEN Restaurant & Bar in San Diego, CA on Wednesday, January 30th from 11:00 am to 2:00 pm. Two of Almac’s subject matter experts, Bryan Thompson and Mark Clayton, will deliver a presentation entitled Playing it cool – cold chain solutions for your clinical supply chain. The presentation will examine challenges faced with a temperature controlled clinical supply chain, and aims to educate attendees on choosing appropriate packaging, labelling, storage, and distribution for temperature sensitive clinical trial materials. 

Almac Clinical Services Production Manager and presentation speaker, Bryan Thompson, comments on the upcoming lunch and learn:

“I am excited to be sharing my knowledge on this important topic. The primary goal of this presentation is for attendees to gain insight on how to execute their clinical trials more effectively based on a solid understanding of managing temperature controlled materials.”

With an increase in biologics and biosimilar type drugs being trialed, there is an increase in demand for cold chain management solutions in order to handle the packaging, labeling, storage and shipping of refrigerated and frozen product.

As industry leading experts, Almac understands the challenges faced by its customers regarding temperature control of clinical trial materials, and hopes that the information presented during this complimentary event can help to guide clinical supply professionals throughout their clinical supply journey. 

Almac Group hopes that this workshop, as well as future workshops, will continue to aid customers in increasing their knowledge around global clinical trial supply services, and to provide them with additional networking opportunities.

To find out more and to sign up to receive information about upcoming events, please visit: https://www.almacgroup.com/clinical-services/cold-chain-solutions-for-your-clinical-supply-chain/

About Almac Group
A unique culture delivering exceptional solutions

The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Our innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation that has grown organically over the past five decades now employing over 5,000 highly skilled personnel across 17 facilities including Europe, the US and Asia. Click here to view our facilities.

We have a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

To keep up to date with our latest releases, follow us on Twitter and LinkedIn

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 15/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.